Related Experiment Video
Updated: Jun 17, 2026

Intra-iliac Artery Injection for Efficient and Selective Modeling of Microscopic Bone Metastasis
Published on: September 26, 2016
Integrins in bone metastasis formation and potential therapeutic implications
1INSERM, UMR 664, IFR62, Lyon, F-69372, and Universitë Lyon 1, Villeurbanne, F-69622, France. philippe.clezardin@inserm.fr
Abstract:
Integrins constitute a family of cell surface receptors that are heterodimers composed of noncovalently associated alpha and beta subunits. Integrins bind to extracellular matrix proteins and immunogobulin superfamily molecules. They exert a stringent control on cell migration, survival and proliferation. However, their expression and functions are often deregulated in cancer, and many lines of evidence implicate them as key regulators during progression from primary tumor growth to metastasis. Here, we review the role of integrins in bone metastasis formation and present evidence that the use of integrin-targeted therapeutic agents may be an efficient strategy to block tumor metastasis.
Insights
Integrins, cell surface receptors regulating cell functions, are crucial in cancer metastasis. Targeting these receptors offers a promising strategy to block tumor spread, particularly in bone metastasis.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Integrins are cell surface receptors crucial for cell adhesion and signaling.
- They regulate cell migration, survival, and proliferation.
- Integrin dysregulation is implicated in cancer progression and metastasis.
Purpose of the Study:
- To review the role of integrins in bone metastasis.
- To present evidence for integrin-targeted therapies in blocking metastasis.
Main Methods:
- Literature review of studies on integrins and bone metastasis.
- Analysis of evidence supporting therapeutic targeting of integrins.
Main Results:
- Integrins play a significant role in the development of bone metastasis.
- Targeting integrins demonstrates potential in inhibiting tumor metastasis.
Conclusions:
- Integrins are key regulators in the bone metastatic cascade.
- Integrin-targeted agents represent a viable therapeutic strategy against cancer metastasis.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Selectins
Mitogens and the Cell Cycle

